Medical Innovation Exchange

Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis

https://www.fiercebiotech.com/biotech/merck-inks-14b-blood-cancer-biotech-buyout-muscle-market-target-bristol-myers-novartis

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!